TNF Antagonists
Links shared publicly online about this topic
TNF Antagonists and Peripheral Neuropathy - Pathophilia
bmartinmd.com — “TNF Antagonists and Peripheral Neuropathy - Pathophilia” View full resource at bmartinmd.com
Most Recently Shared on April 27, 2011 at 2:59 pm By:
Barbara J. Martin Doctor, Neurologist, and Physician
TNF Antagonists and Peripheral Neuropathy: A Montana woman is suing Abbott, the maker of Humira, after she devel... http://bit.ly/ftPXNR
MedWire News - Dermatology - TNF antagonists have favorable benefit-risk profile for psoriasis
medwire-news.md — “MedWire News Tumor necrosis factor antagonists are more likely to be successful for the treatment of psoriasis during the initial year of treatment than they are to cause serious toxicity, quantitative benefit-risk assessment data show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on May 15, 2010 at 9:06 pm By:
TNF antagonists have favorable benefit-risk profile for psoriasis: Tumor necrosis factor antagonists are more like... http://bit.ly/al3vay
MedWire News - Dermatology - Demyelination risk increased during TNF antagonist treatment
medwire-news.md — “MedWire News Central nervous system demyelination risk may be higher than previously believed in psoriasis and other inflammatory disease patients taking tumor necrosis factor ? antagonists, suggest findings from a review of cases in the literature. MedWire News” View full resource at medwire-news.md
Most Recently Shared on March 19, 2012 at 5:06 pm By:
Demyelination risk increased during TNF antagonist treatment http://t.co/A03QlQnC
TNF Antagonist Therapy Reduces Cardiovascular Risk in RA Patients : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on April 28, 2011 at 5:38 pm By:
Bob Finn - Medical News Net Health News
TNF inhibitors associated w reduced cardiovascular risk in rheumatoid arthritis. A.R. Schonfeld reports. http://bit.ly/mKOmZA
Time-dependent increased risk for serious infection from continuous use of TNF antagonists during three years in rheumatoid arthritis patients - Sakai - Arthritis Care & Research - Wiley Online Library
onlinelibrary.wiley.com — “Time-dependent increased risk for serious infection from continuous use of TNF antagonists during three years in rheumatoid arthritis patients - Sakai - Arthritis Care & Research - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 16, 2012 at 1:08 am By:
Time‐dependent increased risk for serious infection from continuous use of TNF antagonists during three years in... http://t.co/wRD8I1z8
Journal of Investigative Dermatology - Abstract of article: TNF-[alpha] Downregulates Filaggrin and Loricrin through c-Jun N-terminal Kinase: Role for TNF-[alpha] Antagonists to Improve Skin Barrier
nature.com — “The Journal of Investigative Dermatology publishes basic and clinical research in cutaneous biology and skin disease.” View full resource at nature.com
Most Recently Shared on June 9, 2011 at 11:27 am By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
TNF-α antagonist results in significant enhancement of epidermal barrier protein expression http://bit.ly/lZaH1M
Initiation of Tumor Necrosis Factor-? Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases - — JAMA
jama.ama-assn.org — “Initiation of Tumor Necrosis Factor-? Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases - — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on November 6, 2011 at 10:55 pm By:
Some drugs to treat #autoimmunediseases do not appear to increase risk of hospitalization. JAMA online from #ACR2011 http://t.co/tHeyLOeC
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis -- Greenberg et al. 70 (4): 576 -- Annals of the Rheumatic Diseases
ard.bmj.com — “Greenberg, Jeffrey D; Kremer, Joel M; Curtis, Jeffrey R; Hochberg, Marc C; Reed, George; Tsao, Peter; Farkouh, Michael E; Nasir, Adeel; Setoguchi, Soko; Solomon, Daniel H” View full resource at ard.bmj.com
Most Recently Shared on March 16, 2011 at 8:08 pm By:
PsoriasisTx.com Dermatology and Health Site
#rheumatology | TNF inhibitiors reduce CV risk in patients with rheumatoid #arthritis. http://ow.ly/4fXsk
How to Pick & Choose: Which Patient & Agent in Biologic-Naive Patients
hcplive.com — “The past decade has seen increased use of TNF antagonists for the treatment of inflammatory bowel disease.” View full resource at hcplive.com
Most Recently Shared on October 20, 2010 at 4:42 pm By:
HCPLive_GastroCMS de Gastroenterology
How to Pick & Choose: Which Patient & Agent in Biologic-Naive Patients -Feagan @ #ACG2010 -http://hcp.lv/c2r8iA
Multiple Sclerosis - Rituximab Infusion: My First Experience
healthcentral.com — “On November 19th, I went to the local hospital outpatient infusion clinic to receive the first dose of Rituxan® (rituximab). This Thursday I go back f...” View full resource at healthcentral.com
Most Recently Shared on December 1, 2009 at 10:50 pm By:
Rituximab Infusion: My First Experience: On November 19th, I went to the local hospital outpatient infusion clinic ... http://bit.ly/8FbGpH
FDA Alert: Rituxan (rituximab) - PML
drugs.com — “FDA Alert: Rituxan (rituximab) - PML” View full resource at drugs.com
Most Recently Shared on October 24, 2009 at 3:51 am By:
FDA Alert - Rituxan (rituximab) - Third Case of PML Reported - http://bit.ly/2blHZY
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 12, 2010 at 12:27 am By:
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis - http://bit.ly/8vWion
HCPLive | The preeminent online destination for tools, techniques, and information for healthcare professionals | Rheumatology | Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis
hcplive.com — “Investigators have identified a biomarker that could help doctors select” View full resource at hcplive.com
Most Recently Shared on January 29, 2010 at 3:55 pm By:
Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis (http://bit.ly/cGXjbW) Interferon beta I predicts treatment response.
FDA Alert: Rituxan (rituximab) - PML
drugs.com — “FDA Alert: Rituxan (rituximab) - PML” View full resource at drugs.com
Most Recently Shared on October 24, 2009 at 2:10 pm By:
RT @drugscom FDA Alert: Rituxan (rituximab) - PML http://bit.ly/2QIfwP
Rheumatology Article | Tumor Necrosis Factors
mdlinx.com — “Age at treatment predicts reason for discontinuation of TNF antagonists: Data from the BIOBADASER 2.0 registry” View full resource at mdlinx.com
Most Recently Shared on August 24, 2011 at 9:01 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Age at treatment predicts reason for discontinuation of TNF antagonists: Data from the BIOBADASER ... http://t.co/89QlSAe #Rheumatology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Barbara J. Martin
Neurologist emeritus, Pathophilia blogger, noir lover
-
Psoriasis OW
Organizing psoriasis resources shared by health experts, advocates, and organizations into WisdomCards.
-
MedWire News
MedWire News is an independent online medical news service.
Advertisement
